Advanced in Vulvovaginitis

Dr. Milroy J. Samuel

Obstetrics and Gynecology | Public Health and Preventive Medicine | Addiction Medicine
Complete Healthcare For Women Inc
111 S Grant Ave, 
Columbus, OH 
Accepting New Patients
Offers Telehealth
Advanced in Vulvovaginitis
Complete Healthcare For Women Inc
111 S Grant Ave, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Milroy Samuel is an Obstetrics and Gynecologist and a Public Health and Preventive Medicine provider in Columbus, Ohio. Dr. Samuel is rated as an Advanced provider by MediFind in the treatment of Vulvovaginitis. His top areas of expertise are Opioid Use Disorder, Opioid Induced Constipation, Vaginal Yeast Infection, and Vulvovaginitis. Dr. Samuel is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Vulvovaginitis.

Specialties
Obstetrics and Gynecology
Public Health and Preventive Medicine
Addiction Medicine
Licenses
Addiction Medicine in OH
Languages Spoken
English
Farsi
French
Hindi
Nepali
Spanish
Tamil
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

COMPLETE HEALTHCARE FOR WOMEN INC
111 S Grant Ave, Columbus, OH 43215

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
Enrollment Status: Completed
Publish Date: August 25, 2023
Intervention Type: Biological, Drug, Device
Study Drugs: VGX-3100, Imiquimod Cream
Study Phase: Phase 2
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: December 20, 2021
Intervention Type: Drug
Study Drug: VT-1161
Study Phase: Phase 3
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Enrollment Status: Terminated
Publish Date: November 23, 2021
Intervention Type: Drug
Study Phase: Phase 4
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)
Enrollment Status: Completed
Publish Date: November 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

1 Total Publications

A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
Journal: Journal of women's health (2002)
Published: January 12, 2018
Similar Doctors
Distinguished in Vulvovaginitis
Dr. David W. Foulk
Obstetrics and Gynecology
Distinguished in Vulvovaginitis
Dr. David W. Foulk
Obstetrics and Gynecology

Marion Area Physicians LLC

960 S Prospect St, 
Marion, OH 
 (42.9 miles away)
740-383-2776
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Foulk is an Obstetrics and Gynecologist in Marion, Ohio. Dr. Foulk is rated as a Distinguished provider by MediFind in the treatment of Vulvovaginitis. His top areas of expertise are Vulvovaginitis, Pelvic Inflammatory Disease, Painful Menstrual Periods, Tubal Ligation, and Intrauterine Device Insertion. Dr. Foulk is currently accepting new patients.

Distinguished in Vulvovaginitis
Dr. Renee M. Caputo
Obstetrics and Gynecology | Urology
Distinguished in Vulvovaginitis
Dr. Renee M. Caputo
Obstetrics and Gynecology | Urology

Central Ohio Urology Group, Llc.

5775 N Meadows Dr, Suite C, 
Grove City, OH 
 (9.4 miles away)
614-221-9262
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Renee Caputo is an Obstetrics and Gynecologist and an Urologist in Grove City, Ohio. Dr. Caputo is rated as a Distinguished provider by MediFind in the treatment of Vulvovaginitis. Her top areas of expertise are Vaginismus, Uterine Prolapse, Vulvovaginitis, and Pelvic Inflammatory Disease. Dr. Caputo is currently accepting new patients.

Advanced in Vulvovaginitis
Dr. Steven P. Balaloski
Obstetrics and Gynecology
Advanced in Vulvovaginitis
Dr. Steven P. Balaloski
Obstetrics and Gynecology

Oh Independent Medical Group LLC

725 Buckles Ct N, Suite 230, 
Gahanna, OH 
 (7.4 miles away)
614-759-6626
Languages Spoken:
English, Bulgarian, Macedonian
See accepted insurances
Accepting New Patients

Steven Balaloski is an Obstetrics and Gynecologist in Gahanna, Ohio. Dr. Balaloski is rated as an Advanced provider by MediFind in the treatment of Vulvovaginitis. His top areas of expertise are Vulvovaginitis, Pelvic Inflammatory Disease, Menorrhagia, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Balaloski is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Samuel's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile